Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IL-6 detection in multiple sclerosis brain

D Maimone1, G C Guazzi, P Annunziata

  • 1Institute of Neurological Sciences, University of Siena, Italy.

Journal of the Neurological Sciences
|February 27, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated exome and transcriptome analysis prioritizes MAP4K4 de novo frameshift variants in autism spectrum disorder as a novel disease-gene association.

Human genetics·2022
Same author

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2022
Same author

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

BMC medical research methodology·2022
Same author

The epidemiology of amyotrophic lateral sclerosis in the Mount Etna region: a possible pathogenic role of volcanogenic metals.

European journal of neurology·2016
Same author

Listeria meningoencephalitis and anti-GQ1b antibody syndrome.

Infection·2016
Same author

Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1.

Gene therapy·2015
Same journal

Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis.

Journal of the neurological sciences·2026
Same journal

Long-term social cognitive impairment after ischemic stroke: Frequency and association with lesion volume and location in an exploratory pilot study.

Journal of the neurological sciences·2026
Same journal

Subjective cognitive decline among U.S. Cancer survivors, 2017-2024: Prevalence, cancer-specific patterns, and associated factors.

Journal of the neurological sciences·2026
Same journal

Comment on "Comparative impact of mental and cardiovascular comorbidities on adverse outcomes in people with MS".

Journal of the neurological sciences·2026
Same journal

Comment on "Efficacy and safety of conventional immunosuppressant therapies in elderly patients with Neuromyelitis optica spectrum disorder: A target trial emulation study".

Journal of the neurological sciences·2026
Same journal

Increasing incidence of varicella-zoster virus meningitis in Japan, 2011-2022.

Journal of the neurological sciences·2026
See all related articles

Interleukin-6 (IL-6) is found in active multiple sclerosis (MS) brain lesions, primarily within astrocytes. This cytokine may have both pro-inflammatory and immunomodulatory roles in MS central nervous system inflammation.

Area of Science:

  • Neuroimmunology
  • Cellular Biology

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS).
  • The role of specific cytokines, such as interleukin-6 (IL-6), in MS pathogenesis is not fully elucidated.

Purpose of the Study:

  • To investigate the cellular localization and distribution of IL-6 within active MS lesions.
  • To explore the potential role of IL-6 in the inflammatory and demyelinating processes in MS.

Main Methods:

  • Double-label immunohistochemistry was employed to detect IL-6 and HLA-DR expression in brain tissue from six MS patients.
  • Cellular association of IL-6 with astrocytes, macrophages, and mononuclear infiltrating cells was analyzed.

Main Results:

Related Experiment Videos

  • IL-6 was detected in both acute and chronic active MS plaques.
  • IL-6 immunoreactivity was predominantly associated with astrocytes, with rare occurrences in macrophages or infiltrating immune cells.
  • The distribution pattern of IL-6 mirrored that of HLA-DR, but colocalization on the same cells was infrequent.

    • Conclusions:

    • In the MS CNS, IL-6 is primarily localized within resident glial cells (astrocytes) at sites of active demyelination and immune activation.
    • While IL-6 possesses pro-inflammatory properties, its predominant localization suggests a potential immunomodulatory role in inflammatory demyelinating disorders like MS.